Welcome to Medications.com

Pacgen Starts Trial for PAC-113 - FDA news (subscription)

The randomized, examiner-blind, parallel-design trial will compare three doses of PAC-113 with Nystatin, a mouth rinse treatment for oral candidiasis. ...

http://fdanews.com/newsletter/art... | Posted: Mon Nov 19 18:41:57 -0500 2007




© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com | Sleep Apnea